Cost-effectiveness of the 21-gene recurrence score assay in the setting of multifactorial decision making for chemotherapy in early-stage breast cancer - Reed, S D; Dinan, M A; Schulman, K A (J Clin Oncol, 2012)
(Suppl.) Abstr. 1525